Dr. Deligiannidis completed her undergraduate degrees and an Honors Scholars Research Program in Neuroscience and Behavior at the University of Massachusetts at Amherst. As a recipient of NIH pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the NIH/National Institutes of Child Health and Human Development (NIH/NICHD). Her research was in the neural regulation of melatonin in the pineal gland.
Dr. Deligiannidis completed additional research training at the National Institute of Mental Health (NIMH) and NICHD during medical school and residency. She received her medical degree from the University of Massachusetts Medical School and completed her psychiatry residency and chief residency in psychopharmacology research at UMass Medical School (UMMS)/UMass Memorial Health Care (UMMHC). Dr. Deligiannidis joined faculty at UMMS in October 2009 as an Assistant Professor of Psychiatry.
Dr. Deligiannidis is the Director of the Depression Specialty Clinic, a regional referral center at UMMHC that specializes in the evaluation and treatment of adult patients suffering from major depression, psychotic depression, treatment-resistant depression and bipolar depression.
Dr. Deligiannidis also evaluates and treats women in the Women’s Mental Health Specialty Clinic at UMMHC. She provides consultation and short-term treatment of women suffering from depression and anxiety during pregnancy or the post-partum period.
Dr. Deligiannidis conducts translational research in the causes of perinatal depression. She evaluates participants enrolled in depression research. Her research interests include:
- Psychoneuroendocrinology (hypothalamic-pituitary-adrenal and gonadal axes, gonadal hormones and neuroactive steroids)
- Neuroimaging and neuroendocrine biomarkers of depression in women during perinatal period
- Gender differences in depression and treatment response
- Neuroimaging (MRS, fMRI, PET)
Dr. Deligiannidis's research efforts have been nationally recognized. She is the recipient of: a 2013-2018 NIH K23 Career Development Award, 2012 Career Development Institute (CDI) for Psychiatry Award (University of Pittsburgh/Stanford University), 2011 UMass Medical School Center for Clinical & Translational Science (CTSA) Pilot Grant, a UMMS Faculty Scholar Award, a 2011 Society for Biological Psychiatry Travel Scholarship Award, a 2010 Worcester Foundation for Biomedical Research Grant; a 2009 NIMH/NCDEU New Investigator Award, APA/APIRE Junior Investigator Awards (2008, 2009) and American Society of Clinical Psychopharmacology/NIMH Clinical Trials in Psychopharmacology Awards (2007, 2008).
Dr. Deligiannidis is an appointed Young Investigator Member of the International Society of Psychoneuroendocrinology (ISPNE) and a member of the Society of Biological Psychiatry (SOBP), the Society of Behavioral Neuroendocrinology (SBE), the Organization for Human Brain Mapping (OHBM), and the American Society of Clinical Psychopharmacology (ASCP). She serves on the Board of Directors of ASCP and on the Trainee Advisory Board for the international journal, Acta Psychiatrica Scandinavica.